Progress in Pediatric Cardiology
Volume 27, Issue 1 , Pages 7-11 , December 2009

Pulmonary arterial hypertension in children: Diagnostic work-up and challenges

References 

  1. Moss and Adams' Heart Disease in Infants, Children and Adolescents: Including the Fetus and Young Adult, Seventh edition. Allen HD, Gutgesell HP, and Clark EB et al. Lippincott Willams and Wilkins, 2007; Chapter 68.
  2. Rosenzweig EB, Widlitz AC, Barst RJ. Pulmonary hypertension in children. Pediatric Pulmonol. 2004;38(1):2–22
  3. McGoon MD, Kane GC. Pulmonary hypertension: diagnosis and management. Mayo Clinic Proc. 2009;84(2):191–207
  4. Kanemoto N. Electrocardiogram in primary pulmonary hypertension. Eur J Cardiol. 1981;12(3–4):181–193
  5. Ahearn GS, Tapson VF, Rebeiz A, Greenfield JC. Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. Chest. 2002;122:524–527
  6. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004;126:14S–34S
  7. Shimada R, Takeshita A, Kasamura M. Noninvasive assessment of right ventricular systolic pressure in atrial septal defect: analysis of the end-systolic configuration of the ventricular septum by two-dimensional echocardiography. Am J Cardiol. 1984;53:1117–1123
  8. Gorcsan J, Edwards TD, Ziady GM, et al. Transesophageal echocardiography to evaluate patients with severe pulmonary hypertension for lung transplantation. Ann Thorac Surg. 1995;59:717–722
  9. Goodman J, Harrison DC, Popp RL. Echocardiographic features of primary pulmonary hypertension. Am J Cardiol. 1974;33:438–443
  10. Louie EK, Rich S, Brundage BH. Doppler echocardiographic assessment of impaired left ventricular filling in patients with right ventricular pressure overload due to primary pulmonary hypertension. J Am Coll Cardiol. 1986;8:1307–1311
  11. Berger M, Haimowitz A, Van Tosh A, et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol. 1985;6:359–365
  12. Fisher MR, Forfia PR, Chamera E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med. 2009;179(7):615–621
  13. Tei C, Dujardin KS, Hodge DO, et al. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr. 1996;9:838–847
  14. Hinderliter AL, Willis PW, Barst RJ, et al. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation. 1997;95:1479–1486
  15. Galie N, Hinderliter AL, Torbicki A, et al. Effects of the oral endothelin receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol. 2003;41:1380–1386
  16. Raymond RJ, Hinderliter AL, Willis PW, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol. 2002;39:1214–1219
  17. Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med. 2006;174:1034–1041
  18. Eysmann SB, Palevsky HI, Reichek N, et al. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation. 1989;80:353–360
  19. Chen WJ, Kuan P, Lian W, et al. Detection of patent foramen ovale by contrast transesophageal echocardiography. Chest. 1992;101:1515–1520
  20. Moser KM, Page GT, Ashburn WL, et al. Perfusion lung scans provide a guide to which patients with apparent primary pulmonary hypertension merit angiography. West J Med. 1988;148:167–170
  21. Fedullo PF, Auger WR, Kerr KM, et al. Chronic thromboembolic pulmonary hypertension. NEJM. 2001;345:1465–1472
  22. Kovacs G, Reiter G, Reiter U, et al. The emerging role of magnetic resonance imaging in the diagnosis and management of pulmonary hypertension. Respiration. 2008;76:458–470
  23. Hoeper MM, Tongers J, Leppert A, et al. Evaluation of right ventricular ejection fraction thermodiluation catheter and MRI in patients with pulmonary hypertension: noninvasive monitoring using MRI. Chest. 2001;120:502–507
  24. van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J. 2007;28:1250–1257
  25. Torbicki A. Cardiac magnetic resonance in pulmonary arterial hypertension: a step in the right direction. Eur Heart J. 2007;28:1187–1189
  26. Lammers AE, Hislop AA, Flynn Y, Haworth SG. The 6-minute walk test: normal values for children of 4–11years of age. Arch Dis Child. 2008;93(6):455–456
  27. Wasserman K, Jansen JE, Sue DY, et al. Principles of exercise testing and interpretation. Philadelphia: Lea and Febinger; 1987;
  28. Garofano RP, Barst RJ. Exercise testing in children with primary pulmonary hypertension. Pediatr Cardiol. 1999;20(1):61–64
  29. Yetman AT, Taylor AL, Doran A, Ivy DD. Utility of cardiopulmonary stress testing in assessing disease severity in children with pulmonary arterial hypertension. Am J Cardiol. 2005;95(5):697–699
  30. Rich S, Kieras K, Hart K, et al. Antinuclear antibodies in primary pulmonary hypertension. J Am Coll Cardiol. 1986;8:1307–1311
  31. Karmochkine M, Cacoub P, Dorent R, et al. High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension. J Rheumatol. 1996;23:286–290
  32. Bernus A, Wagner BD, Accurso F, et al. Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension. Chest. 2009;135:745–751
  33. Nagaya N, Nishikimi T, Uematsu M, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in primary pulmonary hypertension. Circulation. 2000;102:865–870
  34. Fijalkowska A, Kurzyna M, Torbicki A, et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest. 2006;129:1313–1321
  35. D'Alonzo GG, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a natural prospective registry. Ann Intern Med. 1991;115:343–349
  36. Barst RJ. Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension. Chest. 1986;98:497–503
  37. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1991;327:76–81
  38. Houde C, Bohn DJ, Freedom RM, et al. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators. Br Heart J. 1993;70:461–468
  39. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension. Circulation. 2009;119:1–45
  40. Wagenvoort CA. Lung biopsy specimens in e evaluation of pulmonary vascular disease. Chest. 1980;77:614–625
  41. Rabinovitch M, Haworth SG, Castaneda AR, et al. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation. 1978;58:1107–1122

PII: S1058-9813(09)00026-5

doi: 10.1016/j.ppedcard.2009.09.003

Progress in Pediatric Cardiology
Volume 27, Issue 1 , Pages 7-11 , December 2009

Article Tools

* Image Usage & Resolution